肠道微生物群影响PD-L1疗法及其在黑色素瘤中的机制
Shiqi Liu1, Jiahui Liu1, Yingwu Mei2
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Cancer immunology, immunotherapy : CII
|April 11, 2025
概括
免疫检查点抑制剂 (ICI) 对黑色素瘤有希望,但耐药性是一个问题. 肠道微生物群可以通过调节抗瘤免疫来克服这种抵抗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 微生物组研究 微生物组研究
背景情况:
- 免疫检查点抑制剂 (ICI),特别是PD-1/PD-L1阻断,在黑色素瘤治疗中是有效的.
- 与PD-1结合的PD-L1抑制T细胞活动,促进瘤生长,入侵和转移.
- 副作用和耐药性限制了当前抗PD-L1疗法的疗效.
研究的目的:
- 审查黑色素瘤中PD-1/PD-L1通路的机制.
- 探索肠道微生物组在克服抗PD-1疗法耐药性的作用.
- 为改善黑色素瘤治疗策略提供见解.
主要方法:
- 在黑色素瘤中对PD-1/PD-L1机制的文献综述.
- 对将肠道微生物群与抗瘤免疫力联系起来的研究进行分析.
- 检查肠道微生物群代谢物如何影响治疗耐药性.
主要成果:
- 在黑色素瘤的进展和治疗中,PD-1/PD-L1通路至关重要.
- 肠道微生物组的组成会影响抗瘤免疫反应.
- 微生物群可能会重新编程瘤的微环境,以提高ICI的疗效.
结论:
- 肠道微生物组代表了一个潜在的治疗点,以提高ICI在黑色素瘤中的有效性.
- 调节肠道微生物群可以克服对PD-1/PD-L1阻塞的抵抗.
- 对于新的黑色素瘤治疗方法,需要对微生物群与宿主相互作用进行进一步的研究.
相关概念视频
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


